Standard Operating Procedure for Variation Classification and Filing Decision
| Department | Regulatory Affairs |
| SOP No. | RA/2026/665 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 10/04/2026 |
| Effective Date | 10/04/2026 |
| Review Date | 10/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a consistent and compliant process for the classification and filing decision of variations related to approved medicinal products. It aims to ensure that all post-approval changes are appropriately identified, categorized, and submitted in accordance with regulatory requirements, thereby maintaining product quality, safety, and efficacy throughout the product lifecycle.
Scope
This SOP applies to all post-approval variations involving regulatory submissions for changes in product formulation, manufacturing processes, labeling, packaging, equipment qualification, validation activities, and documentation within the Regulatory Affairs department. It covers all pharmaceutical dosage forms and is relevant across functional areas including Quality Assurance, Manufacturing, Engineering, Laboratory, and Quality Control. Activities excluded include initial product registrations and variations falling outside regulatory submission requirements as defined by applicable authorities.
Responsibilities
- Regulatory Affairs Associate/Executive – Responsible for initial assessment and documentation of proposed variations.
- Regulatory Affairs Manager – Reviews classification decisions, ensures compliance, and approves submission strategies.
- Quality Assurance – Supports verification of data integrity and impact assessments related to variations.
- Manufacturing/Technical Team – Provides technical information and impact analysis for the proposed variation.
- Validation/Engineering – Assesses validation status relevant to variation impact.
- Documentation Specialist – Ensures accurate documentation and record control for all variation dossiers.
Accountability
The Regulatory Affairs Head is accountable for the implementation, compliance monitoring, periodic review, escalation of critical deviations, and continuous effectiveness of this SOP. This role ensures alignment with internal policies and external regulatory requirements.
Procedure
The following procedural steps provide a comprehensive and adaptable framework to classify variations and determine appropriate filing actions:
1. Change Identification
Any proposed change affecting approved product(s) is formally identified through internal change control systems or external information sources.
2. Documentation and Initial Assessment
Collect detailed information regarding the nature, scope, and rationale of the change from applicable departments (e.g., Manufacturing, QA, Validation). Regulatory Affairs prepares an initial impact assessment evaluating the potential effect on product quality, safety, efficacy, and compliance.
3. Classification of Variation
Using current regional or international regulatory guidelines, classify the change into categories such as Minor, Moderate, or Major variation (or equivalent terminology). Consider the risk profile, prior approvals, and regulatory precedents. Consult official guidelines (e.g., ICH Q12, regional variation guidelines) to confirm classification.
4. Regulatory Filing Decision
Based on classification, determine if the variation requires prior approval submission, notification only, or can be documented as a minor change without notification. Regulatory Affairs finalizes the filing strategy, timelines, and documentation requirements.
5. Preparation of Variation Dossier
As applicable, prepare the required documentation including updated technical files, validation reports, risk assessments, and justification reports. Ensure adherence to current regulatory dossier formats and documentation controls.
6. Review and Approval
All variation dossiers and classification decisions undergo thorough review by Regulatory Affairs Manager and QA for technical accuracy and compliance. Approvals are documented prior to submission.
7. Submission and Tracking
Regulatory Affairs submits the variation dossier to relevant authorities within defined timelines. The status of the filing is tracked until regulatory approval or acknowledgment is received.
8. Implementation and Record Keeping
Following approval or upon confirmation of no submission requirement, implement the change in accordance with validated processes. Update necessary operational and regulatory files. Retain records securely as per documentation retention policies.
9. Handling Deviations or Discrepancies
Should any discrepancies arise during classification or post-filing, initiate an investigation and document corrective actions. Escalate critical issues to the Regulatory Affairs Head promptly.
10. Periodic Review
Conduct periodic reviews of classification trends and filing outcomes to ensure continuous compliance and identify opportunities for process improvement.
This procedure is designed to be flexible and suitable for regulatory operations across various functional areas while maintaining strict adherence to GMP and regulatory standards.
Abbreviations
- GMP – Good Manufacturing Practice
- QA – Quality Assurance
- RA – Regulatory Affairs
- ICH – International Council for Harmonisation
- QA – Quality Assurance
- QC – Quality Control
- SOP – Standard Operating Procedure
- CSV – Change Submission Variation
Documents
- Variation Classification Assessment Form (Annexure-1)
- Regulatory Filing Decision Checklist (Annexure-2)
- Variation Submission Tracking Log (Annexure-3)
References
- ICH Q12 – Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
- Regional Variation Guidelines (e.g., EMA, FDA, WHO)
- Internal Change Control Policy
- Good Manufacturing Practice (GMP) Guidelines
- Company Quality Management System (QMS) Documentation
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Variation Classification Assessment Form
Purpose: To document and assess the classification of a proposed variation to an approved product in line with regulatory guidelines.
| Variation ID | VAR-2026-001 |
| Date of Assessment | 10/04/2026 |
| Product Name | Product A |
| Description of Variation | Change in manufacturing process parameter |
| Impact on Quality | Minimal – validated process adjustment |
| Impact on Safety/Efficacy | None expected |
| Classification Category | Minor Variation |
| Applicable Regulatory Guideline | EMA Variation Guideline – Category IA |
| Assessed By | |
| Comments | Validated change based on risk assessment |
Annexure-2: Regulatory Filing Decision Checklist
Purpose: To confirm regulatory filing requirements and ensure completeness of supporting documentation for the variation.
| Variation ID | VAR-2026-001 |
| Date | 10/04/2026 |
| Filing Required | Yes |
| Submission Type | Prior Approval Variation |
| Documents Included | Assessment Report, Risk Analysis, Validation Summary |
| Assigned Reviewer | |
| Approval Obtained | Pending |
| Notes | Completed pre-submission review |
Annexure-3: Variation Submission Tracking Log
Purpose: To track submission dates, status updates, and regulatory responses for all variations filed.
| Variation ID | Submission Date | Regulatory Authority | Response Received | Approval Date | Status |
|---|---|---|---|---|---|
| VAR-2026-001 | 15/04/2026 | EMA | 05/05/2026 | 07/05/2026 | Approved |
| VAR-2026-002 | 20/04/2026 | FDA | Pending | Under Review |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 10/04/2026 | 1.0 | Initial issue | New SOP creation |